SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line

Sabine Stöckl(University of Regensburg), Susanne Grässel(University of Regensburg), Gabriele Multhoff(Institute of Neuroimmunology of the Slovak Academy of Sciences), Ferdinand Wagner(Queensland University of Technology), Sebastian Haferkamp(University Hospital Regensburg), Georg Lindner(University Hospital Regensburg), Peter Michael Prodinger(TUM Klinikum), Richard J. Bauer(University Hospital Regensburg), Philipp Schuster(University Hospital Regensburg), Axel Hillmann(Krankenhaus Barmherzige Brüder), Melanie Boxberg(Starnberg Hospital)
International Journal of Molecular Sciences
October 15, 2020
10.3390/ijms21207627
Cited by 13

Related Papers

Osteosarcoma of the spine
|Cancer|2002|282
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|European Journal of Cancer|2021|246
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
|The Lancet|2020|242
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
|European Journal of Cancer|2017|203
Osteoid Osteoma and Osteoblastoma of the Spine: Experiences With 22 Patients
|Clinical Orthopaedics and Related Research|2002|181